AUTHOR=Gargot Julie , Parriault Marie-Claire , Adenis Antoine , Clouzeau Jérôme , Dinh Van Kim-Anh , Ntab Balthazar , Defo Antoine , Nacher Mathieu , Elenga Narcisse 

TITLE=Low Stroke Risk in Children With Sickle Cell Disease in French Guiana: A Retrospective Cohort Study

JOURNAL=Frontiers in Medicine

VOLUME=9

YEAR=2022

URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.851918

DOI=10.3389/fmed.2022.851918

ISSN=2296-858X

ABSTRACT=<p>One in every 227 babies born in French Guiana has sickle cell disease, which represents the greatest incidence in France. This study aimed to determine the incidence of stroke in children with sickle cell disease and its associated risk factors. This retrospective cohort study included all children with sickle cell disease diagnosed in the neonatal period who were born in French Guiana between 01/01/1992 and 12/31/2002. Of a total of 218 records, 122 patients were included. There were 70 HbSS/Sβ0 (58%), 40 HbSC (33%), and 11 Sβ + thalassemia (9%). The number of emergency admissions was significantly different between genotypes, with a higher number in SS/Sβ0 children (<italic>p</italic> = 0.004). There were significantly more acute chest syndromes (<italic>p</italic> = 0.006) and more elevated Lactate Dehydrogenase in SS/Sβ0 patients (<italic>p</italic> = 0.003). Three of these patients had ischemic strokes at a mean age of 6.9 years, and one had a hemorrhagic stroke at the age of 9,2 years. The incidence rate of ischemic stroke for SS/Sβ0 children was 3.1 (95% CI: 1.0–9.7) per 1,000 patient-years, and the clinically apparent stroke risk by the age of 15 years and 3 months was 6,4%. The incidence of hemorrhagic stroke was 1.1 (95% CI: 0.1–7.4) per 1,000 patients-years. No patient with SC or Sβ + thalassemia genotypes experienced any stroke.</p>